Difference between revisions of "Valganciclovir (Valcyte)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
m |
||
| Line 1: | Line 1: | ||
Antiviral with particular activity against cytomegalovirus (CMV). | Antiviral with particular activity against cytomegalovirus (CMV). | ||
| + | |||
| + | ==Also known as== | ||
| + | *'''Brand names:''' Cytomega, VagaCyte, Valcyclovir, Valcyte, Valgan, Valixa, Valnov, Virolfi, V-Gavir | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Revision as of 15:53, 6 August 2019
Antiviral with particular activity against cytomegalovirus (CMV).
Also known as
- Brand names: Cytomega, VagaCyte, Valcyclovir, Valcyte, Valgan, Valixa, Valnov, Virolfi, V-Gavir